Odyssey Health (ODYY) Interest Coverage Ratio (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 86.13% |
| Oct 31, 2025 | -20.33% |
| Jul 31, 2025 | -25.73% |
| Apr 30, 2025 | 14.85% |
| Jan 31, 2025 | 70.70% |
| Oct 31, 2024 | -397.28% |
| Jul 31, 2024 | 177.79% |
| Apr 30, 2024 | 55.44% |
| Jan 31, 2024 | -349.28% |
| Oct 31, 2023 | 55.79% |
| Jul 31, 2023 | 28.78% |
| Apr 30, 2023 | 24.51% |
| Jan 31, 2023 | 73.73% |
| Oct 31, 2022 | -182.56% |
| Jul 31, 2022 | 16.29% |
| Apr 30, 2022 | -30.16% |
| Jan 31, 2022 | -43.61% |
| Oct 31, 2021 | 25.87% |
| Jul 31, 2021 | 73.73% |
| Apr 30, 2021 | -1,157.54% |
| Jan 31, 2021 | 4.58% |
| Oct 31, 2020 | 57.20% |
| Jul 31, 2020 | 0.04% |
| Apr 30, 2020 | -33.49% |
| Jan 31, 2020 | 64.94% |
| Oct 31, 2019 | 98.86% |
| Jul 31, 2019 | -48,045.62% |
| Apr 30, 2019 | 52.15% |
| Jan 31, 2019 | -75.22% |
| Oct 31, 2018 | 35.85% |
| Jul 31, 2018 | -34.62% |
| Apr 30, 2018 | 76.29% |
| Jan 31, 2018 | -320.74% |
| Oct 31, 2017 | 22.81% |
| Jul 31, 2017 | 51.52% |
| Apr 30, 2017 | -87.91% |
| Jan 31, 2017 | -89.60% |
| Oct 31, 2016 | 50.02% |
| Jul 31, 2016 | -764.92% |
| Apr 30, 2016 | 94.27% |
| Jan 31, 2016 | 86.43% |
| Oct 31, 2015 | 63.54% |
| Jul 31, 2015 | 43.50% |
| Apr 30, 2015 | -823.62% |
| Jan 31, 2015 | -253.24% |